Navigation Links
ArcMesa Educators Appoints Medical Advisor and Directors to CME Development Team
Date:9/27/2007

disciplinary training background, he is proficient in drug pharmacology, cell/molecular biology, and physical chemistry. At ArcMesa Educators, Dr. Tacka will assist business development by conducting needs assessments and reviewing proposals, in addition to ensuring programming is scientifically accurate, fair balanced, and ACCME-compliant. Dr. Tacka's role also includes identifying and consulting with key opinion leaders within oncology, cardiovascular disease, and other therapeutic areas.

Duke Duguay, PhD, Assistant Medical Director, is a graduate of Princeton University, where he earned his PhD and MA in molecular biology, and the University of California at Berkeley, where he earned a BA in molecular and cell biology. As assistant medical director, Dr. Duguay will assist with writing educational grants, developing scientific content, supervising freelance writers, and ensuring clinical/scientific accuracy and the necessary fair balance/compliancy rules for all of ArcMesa Educator's scientific programs.

About ArcMesa Educators, LLC

ArcMesa Educators (http://www.arcmesa.com) is a provider of continuing education courses for professionals. Through http://www.CMEdiscovery.com, http://www.OncoUniveristy.com, http://www.NeuroUniversity.com, and http://www.AutoImmuneUniversity.com, ArcMesa Educators offers CME activities to physicians, pharmacists, and nurses. ArcMesa Educators, a full service content developer, holds multiple accreditations including the Accreditation Council for Continuing Medical Education (ACCME) AMA PRA Category 1, the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC). ArcMesa Educators is de
'/>"/>

SOURCE ArcMesa Educators
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Businesses and educators to preview video games for training
2. Exporting The Wisconsin Idea - British Educators Study UW for Role Model of the Future
3. Sharon Ethanol appoints operations director
4. Kyron appoints former AMA chairman to board
5. Brady appoints GE efficiency expert as CTO
6. Merge Healthcare appoints new CEO, reports $215 million Q2 loss
7. Johnson Controls appoints Roell to head EOC
8. SecurePipe appoints two senior execs
9. Milwaukees PointOne appoints new president and CEO
10. Third Wave appoints new chairman
11. Midwest Venture Summit disappoints; Cato grades Midwest governors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... The Conference Forum announced ... Advance Clinical Trials conference taking place on September 19-20 ... , Disruptive thinkers from Novartis, Pfizer, Eli Lilly, ... approaches to reduce expensive infrastructure, engage patients and generate ... be big, or novel, or it must change the ...
(Date:5/22/2013)... 2013  Empire Genomics announced today it has ... novel genomic biomarker from Cornell University for use ... help in diagnosing and determining treatment for patients ... Neuroendocrine prostate cancer (NEPC) is a lethal variant ... novo, but more commonly arises after hormonal therapy ...
(Date:5/22/2013)... CANTON, Mass. and NEW ORLEANS ... commercial leader in the field of regenerative medicine, presented ... expert economists from Analysis Group (a leading health economics ... that diabetic foot ulcers (DFU) and venous leg ulcers ... The results of this research, which reveal annual ...
(Date:5/22/2013)... -- Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that the Company ... Microcap Conference, May 30, in New York, NY ... , CPA, Chief Financial Officer of Cleveland BioLabs, will present ... 1:30 p.m. Eastern Time.  A live and archived webcast of ... of the Cleveland BioLabs website at www.cbiolabs.com . ...
Breaking Biology Technology:Disruptive Innovation Hits Clinical Trials, Dedicated Event Launches 2Empire Genomics Licenses Novel DNA Biomarker for Use in Diagnosing and Creating a Companion Diagnostic Test for Neuroendocrine Prostate Cancer 2Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 2Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 3Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 4Cleveland BioLabs to Present at Second Annual Marcum LLP Microcap Conference 2
... 4, 2011 Tengion, Inc. (Nasdaq: TNGN ), ... a conference call and live audio webcast on Thursday, May ... update and discuss its first quarter 2011 financial results.   ... (domestic) or 1-617-597-5328 (international) and reference access code 64874944. ...
... Researchers at the Institute for Genome Sciences at the ... the FBI, the U.S. Army Medical Research Institute of ... first scientific paper based on their investigation into the ... its use of genomics and microbiology in a criminal ...
... to develop a new drug that will regenerate a ... a person is exposed to deadly chemical warfare agents. ... Ohio State University (OSU), is leveraging Ohio Supercomputer Center ... to lethal chemicals called organophosphorus (OP) nerve agents. ...
Cached Biology Technology:Tengion to Host Conference Call to Provide a Business Update and Report First Quarter 2011 Financial Results on May 12, 2011 2University of Maryland School of Medicine publishes scientific paper on 2001 anthrax attacks 2University of Maryland School of Medicine publishes scientific paper on 2001 anthrax attacks 3University of Maryland School of Medicine publishes scientific paper on 2001 anthrax attacks 4OSU chemist developing solution to nerve agent exposure 2
(Date:5/23/2013)... are billions of animal and plant specimens from birds, ... stacked, stored and preserved in jars and collection drawers. ... to understanding how the Earth,s biodiversity is changing in ... only the information were easily accessible. , A new ... a team from the University of Colorado Boulder, is ...
(Date:5/23/2013)... MADISON, Wis. In an age when microbial pathogens ... to tamp down infection, a team of Wisconsin scientists ... of curbing the bacteria that cause staph infections. , ... Chemical Society , a group led by University of ... interfere with the "quorum sensing" behavior of Staphylococcus ...
(Date:5/22/2013)... durability in fuel cell powered buses, including a ... between electrode degradation processes and bus membrane durability. ... electrode degradation stressors in the operating cycle of ... findings of the study, led by SFU graduate ... long-term study at Burnaby-based Ballard Power Systems and ...
Breaking Biology News(10 mins):CU-Boulder helps tap crowds to digitize museum records of bugs and plants 2CU-Boulder helps tap crowds to digitize museum records of bugs and plants 3CU-Boulder helps tap crowds to digitize museum records of bugs and plants 4University of Wisconsin chemists find new compounds to curb staph infection 2Tests lead to doubling of fuel cell life 2
... A combination of forest byproducts and crustacean shells may ... water, researchers from North Carolina State University have found. ... the major health risks posed by nuclear accidents is ... is chemically identical to non-radioactive iodide, the human body ...
... has been developed to carry out preimplantation genetic screening ... to the recipient uterus in the same in vitro ... The technique has been applied to the ... age, recurrent miscarriages or repeated implantation failures. ...
... NY) Just as inhaling cigarette smoke can cause lung ... Albert Einstein College of Medicine of Yeshiva University have ... of Health to clinically develop an inhaled therapy for lung ... and spreads. The grant recipients are Roman Perez-Soler, M.D., ...
Cached Biology News:Improvements in embryonic preimplantation genetic screening techniques 2NIH funds investigation of inhaled lung cancer treatment 2
Formulation: 10mM PBS/500 mM NaCl, 0.09% NaN3, pH 7.2...
p27 rabbit polyclonal antibody...
Rabbit polyclonal to Shigella (HRP) ( Abpromise for all tested applications)....
Rabbit polyclonal to Aortic Elastin ( Abpromise for all tested applications). entrezGeneID: 2006 SwissProtID: P15502...
Biology Products: